Literature DB >> 19438503

Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?

Stella J Bowcock, Hannah E Patrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438503     DOI: 10.1111/j.1365-2141.2009.07730.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

1.  Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment.

Authors:  Francisco José Fernández-Fernández
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

Review 2.  Advances in the Medical Management of Vascular Anomalies.

Authors:  Kiersten W Ricci
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

Review 3.  Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

Authors:  Steffen K Meurer; Muhammad Alsamman; David Scholten; Ralf Weiskirchen
Journal:  World J Biol Chem       Date:  2014-05-26

4.  Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.

Authors:  Mohamed Aftab Alam; Sarmad Sami; Sathish Babu
Journal:  BMJ Case Rep       Date:  2011-11-08

Review 5.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

Review 6.  Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Authors:  Michael McFarlane; Lauren O'Flynn; Rachel Ventre; Benjamin R Disney
Journal:  Frontline Gastroenterol       Date:  2017-11-02

Review 7.  Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.

Authors:  Daniela S Ardelean; Michelle Letarte
Journal:  Front Genet       Date:  2015-02-11       Impact factor: 4.599

Review 8.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

9.  Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.

Authors:  Haiying Chen; Sengwang Fu; Nan Feng; Huimin Chen; Yunjie Gao; Yunjia Zhao; Hanbing Xue; Yao Zhang; Xiaobo Li; Jun Dai; Jingyuan Fang; Zhizheng Ge
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 10.  Endoglin: a critical mediator of cardiovascular health.

Authors:  Navin K Kapur; Kevin J Morine; Michelle Letarte
Journal:  Vasc Health Risk Manag       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.